On December 12, 2017, Ontario Bill 160, the Strengthening Quality and Accountability for Patients Act, 2017, received Royal Assent. As previously reported, Bill 160 enacts or amends ten statutes (see News Release for highlights), including enacting the Health Sector Payment Transparency Act, 2017 (Transparency Act). When in force, the Transparency Act will require payors, including manufacturers of pharmaceutical or medical devices, to report financial relationships with health care professionals and organizations, as well as other prescribed recipients. The reported information will be made publicly available. Regulations, not yet released, will prescribe many of the details, including the definition of a 'recipient', the manner and frequency of reporting, and which transfers of value will be exempted from reporting. The Health Sector Payment Transparency Act, 2017 will come into force on a day to be named by proclamation of the Lieutenant Governor.
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
